| Name | (3S)-3-[4-[[5-(spiro[indene-1,4'-piperidine]-1'-ylmethyl)-2-thienyl]methoxy]phenyl]hex-4-ynoic acid |
|---|---|
| Synonyms | GPR40 Activator 1 |
| Description | GPR40 Activator 1 is a potent GPR40 activator for treatment of type 2 diabetes.IC50 value:Target: GPR40Preparation of spiropiperidine derivatives for use as antidiabetic agentsBy Hamdouchi, Chafiq; Lineswala, Jayana Pankaj; Maiti, Pranab From PCT Int. Appl. (2011), WO 2011066183 A1 20110603. |
|---|---|
| Related Catalog | |
| References |
[1]. Novel spiropiperidine compounds , Patent WO 2011066183 A1 |
| Molecular Formula | C31H31NO3S |
|---|---|
| Molecular Weight | 497.64800 |
| Exact Mass | 497.20200 |
| PSA | 78.01000 |
| LogP | 6.40720 |
| Storage condition | 2-8℃ |